• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 7
  • 7
  • 4
  • 1
  • 1
  • Tagged with
  • 24
  • 24
  • 7
  • 6
  • 5
  • 5
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
21

Síntese estereosseletiva de α-fenilseleno-β-amino ésteres pela reação do tipo-Mannich e efeito promotor de tiofenol na reação de Pictet-Spengler. / Stereoselective synthesis of α-phenylseleno-β-amino esters by the Mannich-type reaction and promoting effect of thiofenol on the Pictet-Spengler reaction.

Vieira, Adriano Siqueira 21 June 2006 (has links)
Conselho Nacional de Desenvolvimento Científico e Tecnológico / In the present work, it was developed a new methodology for the stereoselective synthesis of α-phenylseleno-β-amino esters by the Mannich-type reaction. These reactions involve chlorotitanium α-phenylseleno esters enolates and aromatic aldimines, affording preferentially the syn-α-phenylseleno-β-amino esters 3a-l in reasonable to good diastereoselectivity, and in 67% to 86% yield. The reactions were carried out with aromatic aldimines with differents substitution paterns in the aromatic ring. Testing the reactivity and the synthetic potential of the α-phenylseleno-β-amino esters, it was observed that the compound 3a reacts with LiHMDS in mild reaction conditions to aford the corresponding anti-α-phenylseleno-β-lactam 4 in 57% yield. Additionally, it was developed an efficient methodology for the synthesis of 1,2,3,4-tetrahydroisoquinolines 7 substituted in the carbon 1, by the activated Pictet-Spengler reaction in the presence of thiophenol, which produces a considerable promoting effect. This reaction was performed with N-tosyl-β-phenethylamines 5 and phenylthioacetals, which were produced 'in situ' by the reaction of thiophenol with an aldehyde under BF3.Et2O catalysis, affording the 1,2,3,4-tetrahydroisoquinolines 7 in 66 to 94% yield. / Neste trabalho, desenvolvemos uma nova metodologia para a obtenção estereosseletiva de α-fenilseleno-β-amino ésteres através da reação do tipo-Mannich. As reações envolvem enolatos de clorotitânio, derivados de α-fenilseleno ésteres 1a-c, e aldiminas aromáticas 2a-h, fornecendo os α-fenilseleno-β-amino ésteres 3a-l com rendimentos que variam de 67 a 86% e com diastereosseletividade de moderadas a boas, onde o diastereoisômero syn foi obtido preferencialmente. Realizou-se reações com aldiminas aromáticas com diferentes padrões de substituição. Ao testar a reatividade e a aplicabilidade sintética dos α-fenilseleno-β-amino ésteres obtidos, observou-se que o composto 3a reage com LiHMDS levando à formação da α- fenilseleno-β-lactama 4 correspondente com estereoquímica anti. Adicionalmente, desenvolvemos uma metodologia sintética eficiente para a obtenção de 1,2,3,4-tetraidroisoquinolinas 7 substituídas na posição 1 através da reação de Pictet-Spengler ativada, na presença de tiofenol, o qual produz um considerável efeito promotor. Nesta reação, empregou-se N-tosil-β-fenetilaminas 5 e feniltio acetais, os quais foram gerados no meio reacional pela reação de um aldeído 6 com tiofenol, sob catálise de BF3.Et2O, fornecendo as 1,2,3,4-tetraidroisoquinolinas 7 com rendimentos que variam entre 66 a 94%.
22

1,3-Disubstituted-tetrahydro-β-carbolines: A New Method for Stereochemical Assignment and Synthesis of Potential Antimalarial Agents

Cagasova, Kristyna 21 June 2021 (has links)
Malaria is a serious mosquito-borne disease affecting the majority of Earth's southern hemisphere. While consistent efforts to curb malaria spread throughout 20th and early 21st century were largely successful, the recent rise in resistance to antimalarial treatments resulted in an increasing incidence rate and stalling mortality rate. This trend clearly signifies the need for the development of novel antimalarial agents able to circumvent current drug-resistance mechanisms. In 2014, in collaboration with Prof. Maria Belen Cassera from the University of Georgia, our group found that compound 1a (1R,3S-MMV008138), discovered from the publicly available Malaria Box, targets an essential biosynthetic pathway (MEP pathway) of malaria-causing parasite Plasmodium falciparum. Analogs of 1a synthesized in our laboratory were found effective against multi-resistant Dd2 strain of P. falciparum which, together with an absence of MEP pathway in humans, suggests that potent analogs of 1a may be safe and efficient antimalarial drug candidates. The initial bioassay studies determined that only one of four possible MMV008138 stereoisomers satisfactorily inhibits the target PfIspD enzyme. Thus a secure determination of stereochemistry in 1a analogs was of utmost importance to the structure-activity relationship studies performed in our group. The second chapter of this work discusses the validation of the previously known empirical stereoassignment method based on analysis of relative shift of 13C NMR resonances between cis and trans diastereomers and compares it to a new method based on 3JHH coupling constants developed in our laboratory. We demonstrate that the new method relying on the analysis of 1H-1H coupling is reliable over large samples of experimental data and suitable even when only a single diastereomer is produced in the synthetic process. Importantly, the origin of 3JHH coupling constants is well understood, unlike the source of relative differences in 13C NMR shifts observed in the older method. The empirical observations for both stereoassignment methods are supported by extensive density-functional theory calculations, which validate the new 1H-1H coupling-based assignment but do not provide a conclusive explanation for the origin of the 13C NMR-based method. In the third chapter, we discuss the replacement of the carboxylic acid moiety in 1a by alternative functional groups promising improved toxicity and bioavailability profile. The total synthesis of tetrazole (trans-23a) and phosphonic acid ((±)-62a) derivatives of 1a is discussed in detail. The tetrazole analog 23a was previously synthesized in the Carlier group as a diastereomeric mixture of cis and trans isomers (dr = 3:7), and it was tested for growth inhibition of multi-resistant P. falciparum with promising results. Later, the synthesis was revisited to obtain a stereochemically pure sample of trans-23a, which was expected to show improved potency compared to the original sample. Furthermore, the synthesis of pure trans-23a confirmed the accuracy of the previous assignment of cis and trans diastereomers in the mixture. Unfortunately, neither analog showed an improvement in potency relative to 1a. / Doctor of Philosophy / The most severe form of malaria disease is caused by the parasite, Plasmodium falciparum, which gives rise to over 200 million infections and more than 400 thousand deaths every year, the majority of which affect young children. In recent years, the effectiveness of clinically used antimalarial medicines decreased due to an increase in drug-resistant strains of P. falciparum. Therefore, there is an urgent need for new antimalarial agents that could bypass the emerging resistance. A promising candidate for a new antimalarial drug is a molecule named MMV008138. This molecule exists in four distinct forms called stereoisomers. Stereoisomers are molecules with the same chemical formula, but the atoms in each molecule are positioned differently. Only one of MMV008138's four stereoisomers (1a) was effective in killing the P. falciparum. The second chapter of this work discusses a new method for identifying stereoisomers in molecules like MMV008138. We demonstrate that the new method is both reliable and simpler than the previously used procedures. The third chapter of this dissertation discusses the preparation of two new compounds based on the structure of 1a that contain modifications promising improved biological activity. Unfortunately, neither of these two molecules was able to kill the P. falciparum efficiently.
23

Exploration moléculaire en série imidazo[2, 1-b][1, 3, 4]thiadiazole : applications à la synthèse d'inhibiteurs de kinases impliqués dans les maladies neurodégénératives / Molecular exploration on imidazo[2,1-b][1,3,4]thiadiazole : applications toward synthesis of kinases inhibitors involved in neurodegenerative diseases

Copin, Chloé 19 December 2013 (has links)
Depuis plus d’un siècle, la chimie hétérocyclique représente l’un des plus vastes domaines de recherche en chimie organique. En particulier, les hétérocycles bicycliques fusionnés à 5 chaînons, contenant à la fois des atomes de soufre et d’azote, présentent, de par leur rareté et leur potentiel biologique, un champ d’intérêt croissant pour les équipes de recherche et développement académiques ou des entreprises pharmaceutiques. Parmi les nombreux composés bicycliques [5-5], notre étude s’est focalisée sur le noyau imidazo[2,1-b][1,3,4]thiadiazole décrit sporadiquement dans la littérature et pour lequel les voies d’accès actuelles ne se limitent qu’à une seule méthode faisant intervenir une étape de cyclisation et des conditions drastiques. Ce verrou entraine inéluctablement une faible diversité fonctionnelle autour de cet hétérocycle, restreignant ainsi les domaines d’applications notamment biologiques. Afin de pallier à cette problématique, nous avons initié une étude de la réactivité de chacune des trois positions fonctionnalisables du bicycle imidazo[2,1-b][1,3,4]thiadiazole, développant ainsi diverses réactions pallado-catalysées (Suzuki-Miyaura, CH-arylation, Buchwald-Hartwig), de substitution nucléophile aromatique et de Pictet-Spengler. L’étude des propriétés biologiques des différents composés synthétisés et hautement valorisables durant ces travaux a abouti à la découverte de deux séries de molécules inhibant sélectivement les kinases DYRK-1A et CLK-1, deux protéines d’intérêt dans le traitement des affections du système nerveux central (neuropathies, Alzheimer…). / For more than a century, heterocyclic chemistry is one of the largest area in organic chemistry research. In particular, because of their rarity and their biological potential, [5-5] fused ring heterocycles containing both sulfur and nitrogen atoms are a large area of interest for both academic and industrial research and development teams. Among these numerous [5-5] bicycles, our study is focused on imidazo[2,1-b][1,3,4]thiadiazole scaffold, which is quite few described in the literature and whose pathways are limited to almost one method involving a cyclisation step and drastic conditions. This lock leads inevitably to low functional diversity around this heterocycle, thus restricting its applications, including biological. In order to overcome this problematic, we then initiated the reactivity study of each three positions of the bicycle imidazo[2,1-b][1,3,4]thiadiazole, developing thereby several palladium couplings (Suzuki-Miyaura, direct arylation, Buchwald-Hartwig), as well as aromatic nucleophilic substitution and Pictet-Spengler reaction. The study of the biological properties of the different compounds synthesized in this work and highly valuable led to the discovery of two series of molecules, inhibiting selectively DYRK-1A and CLK-1, two kinases of interest in the treatment of dysfunction of central nervous system (neuropathies, Alzheimer…).
24

Synthèse et évaluation des propriétés anticancéreuses de nouveaux dérivés de tétrahydro gbs carbolines / Synthesis and evaluation of anti-cancer properties of novel tetrahydro-gbs-carbolines derivatives

Motatu, Iulia-Alexandra 11 February 2015 (has links)
Resumé<p><p>Le cancer reste une maladie grave car il représente une des causes principales de décès dans les pays développés. Plus d'un tiers de cancers solides réagi très faiblement à la chimiothérapie conventionnelle et/ou développe rapidement une résistance au traitement. Des thérapies ciblées, utilisées en association avec les traitements conventionnels, pourraient augmenter la survie des patients. C’est dans le cadre des thérapies ciblées que ce travail de thèse s’inscrit.<p><p>Nous nous sommes intéressés à synthétiser de nouvelles molécules qui pourraient être efficaces contre les cancers résistants à l'apoptose et donc aux traitements conventionnels. La principale cible de notre projet était la kinase DYRK1A, qui a été décrite comme étant impliquée dans la prolifération cellulaire et la résistance à l'apoptose. Dans ce but, une série de nouvelles molécules, principalement des dérivés de la tétrahydro-β-carboline, a été synthétisée et leurs propriétés antitumorales ont été caractérisées in vitro. En effet, ces structures ressemblent à celle de l’harmicine, un alcaloïde apparenté à l’harmine, l’inhibiteur de DYRK1A le plus sélectif et le plus puissant connu à ce jour. <p><p> Une méthodologie "one-pot" très efficace, développée au Laboratoire de Chimie Organique (ULB), a été utilisée pour obtenir les squelettes de type tétrahydro-β-carboline. Le deuxième chapitre de cette thèse détaille cette méthodologie et décrit la librairie de 47 dérivés qui ont été synthétisés. <p><p>Un second objectif de ce travail était de développer une version énantiosélective de cette méthodologie afin de la rendre encore plus intéressante. Cette partie, décrite dans le troisième chapitre, a été réalisée avec succès en collaboration avec l’Unité de Recherche en Chimie Organique et Macromoléculaire de l'Université du Havre (Le Havre, France). Les expériences que nous avons réalisées ont permis, non seulement d'obtenir le composé le plus actif avec un bon excès énantiomérique, mais également de mieux comprendre les aspects mécanistiques qui constituent la base de l'énantiosélectivité. <p><p>L'évaluation des propriétés anticancereuses des composés synthétisés est ensuite détaillée dans le quatrième chapitre. Les analyses toxicologiques et pharmacologiques ont montré que trois molécules présentent une bonne activité antitumorale in vitro avec une sélectivité prometteuse entre les cellules cancéreuses et les cellules normales. D’une manière inattendue, les tests biologiques plus poussés, que nous avons réalisés, ont suggéré que ces molécules n'agissent pas comme des inhibiteurs de kinases. Elles interfèrent en fait sur la prolifération cellulaire, en ciblant des facteurs de transcription spécifiques, par des mécanismes qui doivent encore être élucidés. Ces expériences biologiques ont été réalisées en collaboration avec le Laboratoire de Toxicologie et Cancérologie Expérimentale (ULB).<p><p>/<p><p>Summary<p><p>Cancer is a devastating disease which remains one of the major causes of death in developed countries. More than one third of adult solid cancers respond very poorly to chemotherapy and/or rapidly develop resistance to treatment. Targeted therapies, used in combination with conventional treatments could be used to increase the survival of cancer patients.<p><p>In this work we were interested in developing new molecules related to the targeted therapy concept that could be effective against cancer types that are resistant to apoptosis and thereby to conventional treatments. The leading target of our project was the DYRK1A kinase, which was described as being involved in cell proliferation and resistance to apoptosis. For this purpose, a series of new molecules, mainly tetrahydro β carboline derivatives, has been synthesized and their antitumoral properties were characterized in vitro. Indeed these structures resemble harmicine, an alkaloid similar to harmine, the most selective and potent DYRK1A inhibitor known to date.<p><p> An efficient “one-pot” methodology, developed in the Laboratoire de Chimie Organique (ULB) was used to obtain the tetrahydro β carboline scaffolds. Chapter II of this work describes the use of this methodology for the synthesis of a library of 47 derivatives.<p><p>A second goal of this work was to further improve this methodology by developing an enantioselective version. This part, described in chapter III, was carried out successfully in collaboration with the Research Unit in Macromolecular and Organic Chemistry of Université du Havre (Le Havre, France). The experiments we have performed enabled us not only to obtain the most active compound with a good enantiomeric excess, but also to gain insight of the mechanism responsible for the enantioselectivity.<p><p>The fourth chapter details the evaluation of the anti cancer properties of the synthesised compounds. The pharmacological and toxicological analyses showed that 3 molecules display actual anti-tumor activity in vitro with a promising selectivity between cancerous and normal cells. Surprisingly, further biological assays we have performed suggested that these molecules do not act as kinase inhibitors but influence cell proliferation through the targeting of specific transcription factors by mechanisms that remain to be deciphered. The biological experiments were performed in collaboration with the Cancerology and Experimental Toxicology Laboratory (ULB).<p><p><p><p><p><p> / Doctorat en Sciences / info:eu-repo/semantics/nonPublished

Page generated in 0.0365 seconds